Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to news |u:www.enterprize.cam.ac.uk.  Search for news |u:www.enterprise.cam.ac.uk instead.
41 - 60 of 61 search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Annual Review 2016 111 In 2006 Cambridge Enterprise Limited ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2016_Annual_Report_corrected.pdf
    6 Mar 2017: The new technology developed in the University and licensed to Eight19 in 2016 promises enhanced silicon solar cell e¢ciencies. ... Providing advice to an external customer as a new consultant can be daunting for researchers.
  3. Annual Review 2013 From the Pro-Vice-Chancellor(Research) In…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2013-web.pdf
    6 Jan 2014: achieves a real and. meaningful impact on. society, whether through. new innovations for. ... a revolutionary new treatment for thrombosis; sales. of the quantum modelling software CASTEP passing.
  4. Annual Review 2014 Cover image: With the threat of ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/annual-report-screen-14.pdf
    7 Jan 2015: racing cars, or a new flower seed mix to help bees survive and flourish. ... Those containing active mixtures can be isolated to find rare cells or molecules that cause disease or produce a new medicine.
  5. Bamboo cricket bat

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26236
    24 Jul 2024: DEVELOPED BY RESEARCHERS FROM CAMBRIDGE'S CENTRE FOR NATURAL MATERIAL INNOVATION, THIS NEW BAMBOO.
  6. CE Annual Review 2010-2011:A4

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2010-2011-web.pdf
    19 Dec 2011: 440 disclosures comprising 154 IP disclosures, 232 consultancy. disclosures and 54 new business ideas. ... to new premises, and won a number of awards, including the Medical Futures Innovation Award.
  7. /Where ideas thrive Our 2021 story Highlights from our ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge-Enterprise-Annual-Review-2021-compressed.pdf
    5 Jul 2023: Apollo is now advancing into clinical development as well as identifying new programmes. ... profi le. Evidence included scientifi c papers, government reports, and local news articles.
  8. Scalable Production of High-Quality Printable Graphene

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=27114
    24 Jul 2024: Technology overview. The technology is a new, simple, scalable and effective method toexfoliate graphite into graphene in a controllable way.
  9. CUE Annual Review 06-07:CUE Annual Review 06-07

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/cambridgeenterpriseannualreview2006-07.pdf
    21 Apr 2008: £750,000 was invested in new companies. 72 companies in Cambridge Enterprise equityportfolio. ... www.camfridge.com. Case StudyCase Study. Seed Funds. Practical Support for New Ventures.
  10. Annual Review 2010 From the Pro-Vice-Chancellor(Research) This year…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2009-2010-annual-review-final.pdf
    6 Jan 2011: concept fund. 209 consultancy disclosures received (new consultancy projects). 165 consultancy agreements signed. ... collaboration,providing expert advice through paid consultancy, licensing for commercialisation,creating a new.
  11. Annual Review2019 /Where ideas thrive 2 Cambridge Enterprise Annual…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/03/Cambridge-Enterprise-Annual-Review-2019-1.pdf
    4 Mar 2020: PolyProx Therapeutics exists to develop a new class of drugs, called Polyproxin molecules. ... PolyProx Therapeutics A new class of drugs to halt difficult-to-drug cancers.
  12. Single vessel green ammonia production

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=26240
    24 Jul 2024: High efficiency is achieved through our new heat integration technology using a.
  13. Annual Review 2022 Contents Foreword From the Chair Investment ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf
    26 Mar 2024: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.
  14. IP Policy in Practice Guidance Note 25May10 FINAL CLEAN - Updated…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/IP-Policy-in-Practice-Guidance-Note-25May10-FINAL-CLEAN-Updated-links-August-2015.pdf
    20 Aug 2015: 2. Who should be informed of new IP? Creators who wish to commercialise results are obliged to disclose IP that could be registrable to the University through CE and are also ... The Research Office (RO) will be happy to advise.  To disclose any new
  15. IP Policy in Practice Guidance Note 25May10 FINAL CLEAN - Updated…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/04/IP-Policy-in-Practice-Guidance-Note-25May10-FINAL-CLEAN-Updated-links-August-2015.pdf
    20 Aug 2015: 2. Who should be informed of new IP? Creators who wish to commercialise results are obliged to disclose IP that could be registrable to the University through CE and are also ... The Research Office (RO) will be happy to advise.  To disclose any new
  16. Annual Review 2009 CommercialisationfortheBenefitofSociety Chief…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2008-2009-final.pdf
    9 Mar 2010: will continue to help improve the efficiency of new. builds and reduce costs. ... supporting new innovations and ventures. £62 million raised by 22 of our portfoliocompanies.
  17. LGR5 monoclonal antibody for cancer immunotherapy

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=23572
    24 Jul 2024: LGR5 monoclonal antibody for cancerimmunotherapy. Background. In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rdmost common cancer worldwide. ... As a therapeutic target, LGR5 is relatively new but has been validated in a
  18. Cambridge Enterprise LimitedUniversity of Cambridge10 Trumpington…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2007-2008-final.pdf
    23 Mar 2009: Equity. Transactions. With. Existing. Companies. With. New. Companies. 4 Annual Review 2007–2008. ... particular expertise and equipment in this area. Highlights 124 new consultancy disclosures received.
  19. Annual Review 2022 Contents Foreword From the Chair Investment ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf
    3 Jul 2023: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.
  20. MAT2A inhibitors to treat BK polyomavirus disease

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=28102
    24 Jul 2024: The groundbreakingdiscovery opens new avenues for antiviral drug development and offers apromising therapeutic option for BKPyV-associated diseases, addressing thelimitations of available treatments. ... Taken together, these resultshighlight the
  21. PowerPoint Presentation

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/11/Marketing-Sheet_Low-loss-high-speed-data-transmission_Mol-7671-20_18-11-2021.pdf
    18 Nov 2021: the University of Cambridge have developed a new data transmission design based on a pair of Goubau Lines – metallic tracks or wires with a carefully defined separation, tailored to the frequency ... By using an appropriate antenna as a “launcher”

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.